Next‐generation sequencing (NGS) analysis of the patient's renal tumor revealed the following heterozygous somatic alterations: FH (NM_000143 ‐ 1q43) intragenic deletion involving the loss of exon 1–2, KDM5C (NM_004187) exon 7 p.K289E (c.865A > G), and NUF2 (NM_031423) exon 8 p.S171C (c.512C > G). The gene discussed is FH; the disease is kidney neoplasm.